Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782169 · ClinicalTrials.gov registry record · Phase 4
Prophylactic Pregabalin to Decrease Pain During Medical Abortion
A Phase 4 study, sponsored by University of Hawaii.
- Completed
- Registry status
- Phase 4
- Development phase
- 110
- Enrollment target
NCT02782169 is a Phase 4 study that has completed, run by University of Hawaii. The registered enrollment target is 110 participants.
The verdict
NCT02782169, a Phase 4 study, has completed, sponsored by University of Hawaii.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 110 participants
- Enrollment target
Study Summary
Medical abortion has been associated with significant pain. The objective of this trial is to determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to the standard of care analgesics, will decrease experienced pain. Investigators will perform a randomized, double-blinded, placebo-controlled trial. Participant pain levels and side effects will be assessed at multiple time points, along with a measure of satisfaction.
Interventions
- DRUG Placebo
- DRUG Pregabalin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2015-06 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02782169
The ClinicalTrials.gov registry entry for NCT02782169 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 110 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Hawaii, which has 77 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT02782169 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02782169 about?
NCT02782169 is a clinical study titled "Prophylactic Pregabalin to Decrease Pain During Medical Abortion". Medical abortion has been associated with significant pain. The objective of this trial is to determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to the standard of care analgesics, will decrease experienced pain. Investigators will perform a randomized, double...
What is the current status of trial NCT02782169?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 110 participants. The study started on 2015-06. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02782169?
The interventions under investigation include: Placebo (DRUG), Pregabalin (DRUG).
Who is sponsoring clinical trial NCT02782169?
This trial is sponsored by University of Hawaii, which has 77 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.